Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Union
Grant: SF1401
National Institutes of Health
Grant: U01AI152087
European & Developing Countries Clinical Trials Partnership (EDCTP)
Grant: TMA 2015 SF - 1041
National Institutes of Health
Grant: 5U01AI152087-03
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
National Research Foundation
European & Developing Countries Clinical Trials Partnership (EDCTP)
National Institute of Allergy and Infection Diseases
South African Medical Research Council
Harry Crossley
Stellenbosch University Faculty of Health Sciences
FWCI
1.45
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals